The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Perimenopause — What You Need to Know
Perimenopause can make weight management more challenging due to hormonal fluctuations that affect appetite, metabolism, and where your body stores fat. Many UK adults wonder whether Mounjaro (tirzepatide) can still help during this life stage. The evidence suggests it may, though your individual experience will depend on your specific hormonal changes, overall health, and lifestyle. This guide explains how Mounjaro works, what perimenopause does to your weight, and what to expect if you're considering this prescription medication during this transition.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Perimenopause Affects Weight
Perimenopause — the transition period before menopause, typically lasting 4–10 years — brings significant hormonal shifts that directly impact weight management. Oestrogen and progesterone levels fluctuate unpredictably, which can increase appetite, slow metabolism by up to 5%, and increase fat storage around the abdomen and hips. Many UK women report weight gain of 0.5–1 kg per year during perimenopause, even without dietary changes.
- Increased hunger: Fluctuating oestrogen reduces serotonin and increases ghrelin (the "hunger hormone")
- Slower metabolism: Lower oestrogen = reduced calorie burning at rest
- Water retention: Progesterone changes can cause bloating and apparent weight gain
- Changed fat distribution: Hormonal shifts favour fat storage around the midsection rather than hips and thighs
These changes mean traditional weight loss approaches may feel less effective, and many people find they need additional support — which is where prescription medications like Mounjaro may help.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Can Mounjaro Help During Perimenopause?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for weight management in UK adults. It works by activating two natural hormone pathways that regulate appetite and fullness — mechanisms that operate independently of oestrogen and progesterone. This means Mounjaro may help reduce the increased hunger and cravings associated with perimenopause, and support feeling fuller after smaller meals. Clinical trial data shows average weight loss of 15–21% over 72 weeks when combined with lifestyle changes, though individual results vary significantly.
If you're in perimenopause and considering Mounjaro, discuss with your GP or a licensed prescriber whether it's appropriate for your situation. They can assess your overall health, current medications, and hormonal status to determine if tirzepatide is suitable. Use our free GLP-1 weight loss calculator to explore projected outcomes at different doses, and our BMI calculator to track your baseline health metrics.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro work differently in perimenopause?
No — Mounjaro's mechanism (GIP and GLP-1 activation) is independent of oestrogen and progesterone. However, perimenopause-related hunger may be particularly responsive to appetite-suppressing medication. Individual effectiveness varies based on overall health, weight, and lifestyle. Your prescriber can assess your suitability.
Will Mounjaro affect my hormone levels or menopause symptoms?
Mounjaro does not directly interact with oestrogen or progesterone. It should not worsen or improve hot flushes, night sweats, or mood changes. However, weight loss itself can sometimes reduce severity of some menopause symptoms. Always inform your prescriber of current hormone-related medications.
Can I use Mounjaro if I'm on HRT?
Mounjaro can be used alongside HRT, but inform your prescriber of all medications. HRT does not contraindicate tirzepatide. However, HRT can slightly increase blood clotting risk, so your prescriber will assess your individual profile. Never stop HRT without consulting your GP.
What if Mounjaro causes nausea during perimenopause?
Nausea is common with Mounjaro, especially during dose escalation. Perimenopause nausea from hormonal changes may compound this. Strategies include eating smaller meals, avoiding fatty foods, and staying hydrated. Nausea typically improves after 4–8 weeks. Contact your prescriber if it persists or severely impacts quality of life.
Is weight loss during perimenopause safe with Mounjaro?
Yes, when guided by a healthcare professional. The NHS recommends losing 0.5–1 kg per week as sustainable and safe. Mounjaro combined with reduced-calorie diet and physical activity supports this rate. Your prescriber will monitor your health and adjust treatment as needed throughout perimenopause.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.